75
Views
1
CrossRef citations to date
0
Altmetric
Original Research

NMDA receptor regulation of levodopa-induced behavior and changes in striatal G protein-coupled receptor kinase 6 and â-arrestin-1 expression in parkinsonian rats

, , , &
Pages 347-352 | Published online: 26 Mar 2013

References

  • CenciMAL-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatmentParkinsonism Relat Disord200713Suppl 3263267
  • ObesoJAOlanouCWNuttJGLevodopa motor complications in Parkinson’s diseaseTrends Neurosci200023Suppl 10S2S711052214
  • CalabresiPPicconiBTozziADi FilippoMDopamine-mediated regulation of corticostriatal synaptic plasticityTrends Neurosci200730521121917367873
  • ThanviBLoNRobinsonTLevodopa-induced dyskinesia in Parkinson’s disease: clinical features, pathogenesis, prevention and treatmentPostgrad Med J20078398038438817551069
  • StandaertDGTestaCMYoungABPenneyJBJrOrganization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the ratJ Comp Neurol199434311168027428
  • KongMBaMSongLLiuZComparative effects of acute or chronic administration of levodopa to 6-OHDA-lesioned rats on the expression and phosphorylation of N-methyl-D-aspartate receptor NR1 subunits in the striatumNeurochem Res20093481513152119283475
  • RobeletSMelonCGuilletBSalinPKerkerian-Le GoffLChronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson’s diseaseEur J Neurosci20042051255126615341597
  • DunahAWWangYYasudaRPAlterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson’s diseaseMol Pharmacol200057234235210648644
  • BaMKongMYangHChanges in subcellular distribution and phosphorylation of GluR1 in lesioned striatum of 6- hydroxydopamine-lesioned and L-dopa-treated ratsNeurochem Res200631111337134717053970
  • BibbianiFOhJDKielaiteACollinsMASmithCChaseTNCombined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PDExp Neurol2005196242242916203001
  • Hadj TaharAGregoireLDarreABelangerNMeltzerLBedardPJEffect of a selective glutamate antagonist on L-dopa-induced dyskinesias in drug-naïve parkinsonian monkeysNeurobiol Dis200415217117615006686
  • LugingerEWenningGKBoschSPoeweWBeneficial effects of amantadine on L-dopa-induced dyskinesias in Parkinson’s diseaseMov Disord200015587387811009193
  • LundbladMAnderssonMWinklerCKirkDWierupNCenciMAPharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson’s diseaseEur J Neurosci200215112013211860512
  • PapaSMChaseTNLevodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeysAnn Neurol19963955745788619541
  • Verhagen MetmanLDel DottoPvan den MunchhofPFangJMouradianMMChaseTNAmantadine as treatment for dyskinesias and motor fluctuations in Parkinson’s diseaseNeurology1998505132313269595981
  • PremontRTGainetdinovRRPhysiological roles of G protein-coupled receptor kinases and arrestinsAnnu Rev Physiol20076951153417305472
  • AhmedMRBychkovEGurevichVVBenovicJLGurevichEVAltered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized by L-dopa treatmentJ Neurochem200810461622163617996024
  • Erdtmann-VourliotisMMayerPAmmonSRiechertUHölltVDistribution of G protein-coupled receptor kinase (GRK) isoforms 2, 3, 5 and 6 mRNA in the rat brainMol Brain Res2001951–212913711687284
  • AhmedMRGurevichVVDalbyKNBenovicJLGurevichEVHaloperidol and clozapine differentially affect the expression of arrestins, receptor kinases, and extracellular signal-regulated kinase activationJ Pharmacol Exp Ther2008325127628318178904
  • DeWireSMAhnSLefkowitzRJShenoySKÂ arrestins and cell signalingAnnu Rev Physiol20076948351017305471
  • GurevichEVBenovicJLGurevichVVArrestin2 and arrestin3 are differentially expressed in the rat brain during postnatal developmentNeuroscience2002109342143611823056
  • GainetdinovRRBohnLMSotnikovaTDDopaminergic super-sensitivity in G protein-coupled receptor kinase 6-deficient miceNeuron200338229130312718862
  • AhmedMRBerthetABychkovELentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson’s diseaseSci Transl Med201022828ra28
  • ManagoFEspinozaSSalahpourAThe role of GRK6 in animal models of Parkinson’s disease and L-dopa treatmentSci Rep2012230122393477
  • PaxinosGWatsonCThe Rat Brain in Stereotaxic Coordinates4th edNew York, NYAcademic Press1998
  • DeumensRBloklandAPrickaertsJModeling Parkinson’s disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathwayExp Neurol2002175230331712061862
  • GurevichVVGurevichEVThe structural basis of arrestin mediated regulation of G protein coupled receptorsPharmacol Ther2006110346550216460808
  • LuttrellLMLefkowitzRJThe role of â-arrestins in the termination and transduction of G-protein-coupled receptor signalsCell Sci2002115Pt 3455465
  • PerrySJLefkowitzRJArresting developments in heptahelical receptor signaling and regulationTrends Cell Biol200212313013811859025